Yalla Green Mobility Show Set to Make History with UAE’s Largest Sustainable Test Drive Event
Participants achieved an average weight loss of 20.2% with tirzepatide vs. 13.7% with semaglutide In key secondary endpoints, tirzepatide was superior to semaglutide across all weight reduction targets and waist circumference reduction. Dubai, United Arab Emirates, May 12, 2025 Read More